ARCHIVES

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

DCT Board Okays Recompetitions

June 21, 1985

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Senate Markup Of Labor-HSS-Education Money Bill Delayed Until After Congress August Recess

August 4, 1989

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995